Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological features of lung adenocarcinoma with KRAS mutations.

Cancer - 15 Sept 2011

Kakegawa Seiichi, Shimizu Kimihiro, Sugano Masayuki, Miyamae Yohei, Kaira Kyoichi, Araki Takuya, Nakano Tetsuhiro, Kamiyoshihara Mitsuhiro, Kawashima Osamu, Takeyoshi Izumi

Abstract excerpt

BACKGROUND: KRAS and epidermal growth factor receptor (EGFR) mutations are thought to play an important role in the carcinogenesis of lung adenocarcinoma. However, clinicopathological findings of KRAS mutated adenocarcinoma cases have not yet been fully clarified. The authors analyzed the relationship between the KRAS mutation and corresponding clinicopathological findings, focusing on nonmucinous and mucinous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma, Bronchiolo-Alveolar

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Adenocarcinoma, Mucinous

Share to Adenocarcinoma of Lung

Share to ErbB Receptors

Share to Lung Neoplasms

Share to ras Proteins

Share to Smoking

Source

Identifiers

PMID: 21387273
DOI: 10.1002/cncr.26010

Genes

KRAS
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological features of lung adenocarcinoma with KRAS mutations.PMID 21387273Read ↗

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populationsSemantic proximity Read ↗

Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.Semantic proximity Read ↗

KRAS Mutations in Squamous Cell Carcinomas of the LungSemantic proximity Read ↗

Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.Semantic proximity Read ↗

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.Semantic proximity Read ↗

Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.Semantic proximity Read ↗

Clinicopathological Features and Prognosis of Lung Adenocarcinoma Patients With K-RAS Gene Mutation.Semantic proximity Read ↗

Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.Semantic proximity Read ↗

Peripheral lung adenocarcinomas with KRAS mutations are more likely to invade visceral pleura.Semantic proximity Read ↗

[Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma].Semantic proximity Read ↗

Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications.Semantic proximity Read ↗

Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.